$310 Million is the total value of Nextech Invest Ltd.'s 14 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RVMD | Buy | REVOLUTION MEDICINES INC | $82,618,000 | +7.6% | 4,189,529 | +6.3% | 26.68% | +3.0% |
| EQRX INC | $64,867,000 | +5.5% | 13,104,424 | 0.0% | 20.95% | +1.1% | ||
| KNTE | Sell | KINNATE BIOPHARMA INC | $31,810,000 | -16.1% | 2,661,888 | -11.5% | 10.27% | -19.7% |
| TYRA BIOSCIENCES INC | $22,138,000 | +22.9% | 2,518,582 | 0.0% | 7.15% | +17.7% | ||
| MRTX | MIRATI THERAPEUTICS INC | $18,432,000 | +4.0% | 263,914 | 0.0% | 5.95% | -0.4% | |
| PMVP | PMV PHARMACEUTICALS INC | $16,491,000 | -16.5% | 1,385,807 | 0.0% | 5.33% | -20.0% | |
| CGEM | CULLINAN ONCOLOGY INC | $15,655,000 | 0.0% | 1,221,145 | 0.0% | 5.06% | -4.3% | |
| ARVN | ARVINAS INC | $12,780,000 | +5.7% | 287,251 | 0.0% | 4.13% | +1.2% | |
| BPMC | BLUEPRINT MEDICINES CORP | $12,402,000 | +30.5% | 188,228 | 0.0% | 4.01% | +24.9% | |
| RLAY | RELAY THERAPEUTICS INC | $10,637,000 | +33.6% | 475,485 | 0.0% | 3.44% | +27.9% | |
| SBTX | SILVERBACK THERAPEUTICS INC | $10,085,000 | +24.5% | 1,910,029 | 0.0% | 3.26% | +19.2% | |
| KRON | KRONOS BIO INC | $4,863,000 | -8.0% | 1,451,537 | 0.0% | 1.57% | -11.8% | |
| THESEUS PHARMACEUTICALS INC | $3,546,000 | +4.9% | 611,310 | 0.0% | 1.14% | +0.4% | ||
| CCCC | C4 THERAPEUTICS INC | $3,296,000 | +16.3% | 375,857 | 0.0% | 1.06% | +11.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| REVOLUTION MEDICINES INC | 8 | Q3 2023 | 44.0% |
| EQRX INC | 8 | Q3 2023 | 23.5% |
| TYRA BIOSCIENCES INC | 8 | Q3 2023 | 16.9% |
| KINNATE BIOPHARMA INC | 8 | Q3 2023 | 14.0% |
| CULLINAN ONCOLOGY INC | 8 | Q3 2023 | 5.3% |
| PMV PHARMACEUTICALS INC | 8 | Q3 2023 | 8.4% |
| ARVINAS INC | 8 | Q3 2023 | 6.2% |
| SILVERBACK THERAPEUTICS INC | 8 | Q3 2023 | 6.5% |
| KRONOS BIO INC | 8 | Q3 2023 | 5.2% |
| THESEUS PHARMACEUTICALS INC | 8 | Q3 2023 | 2.3% |
View Nextech Invest Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-01 |
| 13F-HR/A | 2022-05-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Nextech Invest Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.